冠状动脉高度≤7 mm患者行经导管主动脉瓣植入术的可行性:来自经导管主动脉瓣植入术卡尔斯鲁厄(TAVIK)登记研究的结果
该研究基于TAVIK前瞻性登记中86例冠状动脉高度≤7 mm的患者,分析经导管主动脉瓣植入术(TAVI)围术期及术后结局。手术成功率为95.3%,随访死亡与瓣中瓣(VinV)手术相关(P<0.001;风险比7.96)。作者认为此类手术可行,但需细致术前规划,且不推荐VinV手术。
要点
- 冠状动脉高度≤7 mm患者行TAVI的冠状动脉相关并发症较少但一旦发生则严重。
- 手术成功率为95.3%,随访(3.0±1.6年)死亡率为26.7%。
- VinV手术与随访死亡增加相关(P<0.001;风险比7.96),作者不推荐该手术。
核心结论
- 冠状动脉高度≤7 mm患者行TAVI的冠状动脉相关并发症发生频率较低,但一旦发生则严重。
- 此类TAVI手术可行且手术成功率高,但细致的术前规划应被强制执行。
- 在VinV手术中随访死亡率增加,因此作者不推荐这些手术。
研究设计与样本
- 自2008年5月起,机构TAVIK登记研究前瞻性收集了超过3000例接受TAVI患者的数据。
- 根据Valve Academic Research Consortium-2标准,分析冠状动脉高度≤7 mm患者的特征及围术期和术后结局。
- 共纳入86例患者,平均冠状动脉高度6.4±1.1 mm,平均年龄81.0±5.3岁,logistic EuroSCORE I为19.6±13.3%。
主要发现
- TAVI入路为经股动脉72例(83.7%)和经心尖14例(16.3%)。
- 使用瓣膜:CoreValve/Evolut R 44例(51.2%)、Sapien XT/S3 21例(24.4%)、ACURATE 14例(16.3%)、Lotus 5例(5.8%)、Portico 2例(2.3%)。
- 瓣中瓣(VinV)TAVI共10例(11.6%)。
- 72小时、30天、1年及随访(3.0±1.6年)死亡率分别为2.3%、8.0%、10.5%和26.7%。
- 30天内发生4例心源性死亡和3例非心源性死亡(4.7%和3.5%)。
临床怎么用
- 作者认为,冠状动脉高度≤7 mm患者行TAVI可行且手术成功率高,但细致的术前规划应被强制执行。
- 作者不推荐在VinV手术中行TAVI,因随访死亡率增加。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Transcatheter aortic valve implantation (TAVI) in patients with low coronary heights is generally denied but is not impossible. Information about these high-risk procedures is sparse. METHODS: Since May 2008, data of more than 3000 patients who had TAVI were prospectively collected in the institutional TAVI Karlsruhe registry. Characteristics, peri- and postoperative outcome of patients with low coronary heights of ≤7 mm were analysed according to the Valve Academic Research Consortium-2. RESULTS: Eighty-six patients with an average coronary height of 6.4 ± 1.1 mm (mean age 81.0 ± 5.3 years, logistic EuroSCORE I 19.6 ± 13.3%) were treated. TAVI was performed in 72 transfemoral (83.7%) and 14 transapical (16.3%) cases using 44 CoreValve/Evolut R (51.2%), 21 Sapien XT/S3 (24.4%), 14 ACURATE (16.3%), 5 Lotus (5.8%) and 2 Portico (2.3%) prostheses. Ten procedures were valve-in-valve (VinV) TAVI (VinV, 11.6%). The 72-h, 30-day, 1-year and follow-up (3.0 ± 1.6 years) mortality rates were 2.3%, 8.0%, 10.5% and 26.7%, respectively. Within 30 days, 4 cardiac deaths and 3 non-cardiac deaths occurred (4.7% and 3.5%). Three coronary obstructions (3.5%) occurred-2 during VinV TAVI. One patient was connected to extracorporeal circulation that could not be weaned later due to an unsuccessful percutaneous coronary intervention. Another patient, the only conversion (1.2%), required delayed surgical valve replacement. The third patient died of right heart failure after aortic dissection. The procedural success rate was 95.3%. VinV procedures were associated with increased follow-up deaths (P < 0.001; hazard ratio 7.96). CONCLUSIONS: Coronary-related complications in TAVI procedures in patients with coronary heights ≤7 mm occurred less frequently, but once they occurred, they were serious. These TAVI procedures are feasible, with a high procedural success rate, but meticulous preoperative planning should be mandatory. In VinV procedures, the follow-up mortality rate is increased; therefore, we do not recommend these procedures.
引用
- Conzelmann LO, Würth A, Schymik G, et al. Feasibility of transcatheter aortic valve implantation in patients with coronary heights ≤7 mm: insights from the transcatheter aortic valve implantation Karlsruhe (TAVIK) registry. Eur J Cardiothorac Surg. 2018. PMID: 29617804. doi:10.1093/ejcts/ezy130
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。